With the MD Financial sale, the CMA sold off arguably its most valuable offering to doctors to ensure the association’s continued relevance—but the result may have been the opposite.
Council capped the redistribution of overvalued specialist fees at a maximum of 1% per year, only to be used if allocation of pay increases doesn't address relativity
